The FORMAMP project focus on innovative nanoformulation design of antimicrobial peptides

The long-term objective of the FORMAMP project is to significantly change the treatment strategies for infectious diseases and to reduce the drastic increase of resistant bacteria.

The project aims to develop new and innovative formulation strategies, based on the combination of nanotechnology-based delivery systems and antimicrobial peptides (AMPs), for the treatment of infectious diseases caused by bacteria such as Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus (MRSA), and Mycobacterium tuberculosis.

FORMAMP is funded by the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no 604182.



Latest news

New FORMAMP article published in Frontiers in Cellular and Infection Microbiolgy

Bildresultat för frontiers in cellular and infection microbiology

We are pleased to announce that a review article has been published in Frontiers in Cellular and Infection Microbiolgy authored by Margit Mahlapuu, Joakim Håkansson, Lovisa Ringstad and Camilla Björn from FORMAMP partners Pergamum (Promore Pharma) and SP Technical Research Institute of Sweden as well as The Sahlgrenska Academy at University of Gothenburg.

The article is publicly available as can be accessed from the link below:
http://journal.frontiersin.org/article/10.3389/fcimb.2016.00194/full

FORMAMP Newsletter #2

FORMAMP newsletter July 2016_mini

The FORMAMP project has released its second newsletter. Read about new initiatives within antimicrobial resistance and the exciting developments within the project, including several publications on the project’s important research.

Click here to download the newsletter (pdf)

Click here to subscribe to our upcoming newsletters

Latest tweets